grant

Enabling a rapid transition from synthase to structure

Organization UNIVERSITY OF CALIFORNIA, SAN DIEGOLocation LA JOLLA, UNITED STATESPosted 1 Jun 2024Deadline 31 May 2026
NIHUS FederalResearch GrantFY20244'-phosphopantetheinyl transferaseAcyl Carrier ProteinAcyltransferaseAffinityAnabolismAnti-Cancer AgentsAntineoplastic AgentsAntineoplastic DrugsAntineoplasticsCancer DrugCancer TreatmentCatalysisCell BodyCellsChemotherapy ProtocolChemotherapy RegimenChemotherapy-Oncologic ProcedureClinicalCodonCodon NucleotidesCombination Chemotherapy RegimenComplexCrosslinkerCryo-electron MicroscopyCryoelectron MicroscopyDevelopmentDockingEC 2.3Electron CryomicroscopyEngineeringEnzyme GeneEnzymesEvaluationExclusionFamilyFutureGoalsIndividualKnock-outKnockoutKnowledgeLaboratoriesMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMasksMechanicsMethodsModelingModificationMovementNatural ProductsNeoplastic Disease Chemotherapeutic AgentsOncologyOncology CancerOrganismPK/PDPKS enzymePathway interactionsPeptide DomainPlayProcessProductionPropertyProtein DomainsProteinsQuimioterapiaRecombinantsResolutionRoleSamplingSeriesSiteSpliceosomesStreptomycesStructureSystemTechniquesTechnologyTertiary Protein StructureTherapeuticTumor-Specific Treatment AgentsType I Polyketide Synthaseanti-canceranti-cancer druganti-cancer therapybiosynthesisbody movementcancer chemotherapycancer therapycancer-directed therapychemical synthesisclinical translationclinically translatablecrosslinkcryo-EMcryoEMcryogenic electron microscopydesigndesigningdevelopmentalimprovedinsightliving systemmechanicmechanicalnaturally occurring productoverexpressoverexpressionpathwaypharmacokinetics and pharmacodynamicsphosphopantetheinyl transferasepolyketide synthasepolyketidesprogramsprotein expressionprotein purificationresolutionssocial rolesuccesssurfactin synthetase-activating enzymetooltrendtumor
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary. Polyketide natural products have played, and will continue to play, critical roles in cancer
chemotherapy. Though they are potent and often tumor-selective agents, access to gram scale supplies of these

agents complicates their clinical translation. Current solutions, including chemical synthesis and strain

optimization, have provided modest success, but our lack in understanding the machines responsible for their

production ultimately limits the ability to attain effective levels of production. Type I polyketide synthases (PKSs)

are large multifunctional enzymes that are organized into modules of discrete enzymatic proteins, minimally

containing a β-ketoacyl synthase, an acyltransferase, and an acyl carrier protein (ACP). While an ideal size for

cryo-electron microscopy (cryo-EM), only a few Type I PKS structures currently exist, and of these many lack

resolution of their ACP domain. Like many large proteins, they exist naturally in a highly dynamic state, wherein

their activity operates through discrete, mechanical processes. In most Type I PKSs, biosynthesis arises through

assembly of ketide units, which are shuttled between the enzymatic domains by means of the ACP. Here, the

complex movement between domains in each module results in synchronic capture of multiple states of the

same protein, therein complicating structural evaluation. In this program, our team explores the pathways to

enable the selective evaluation of state trapped Type I PKSs. Through two specific aims, we offer a unique

solution towards isolating PKS megasynthases from host cells or producing them through recombinant

technologies for cryo-EM studies. Overall, two key fundamental discoveries will arise from this program: an

approach to isolating PKS enzymes for cryo-EM studies by directly challenging the current methods; and a

primary understanding of the selectivity and mechanics involved in PKS catalysis. We anticipate that this

program will offer not only a basis for structural resolution of large PKS enzymes, but also offer insight into

modular and intermodular dynamics within these complex multimodular synthases.

Grant Number: 1R21CA280558-01A1
NIH Institute/Center: NIH

Principal Investigator: Michael Burkart

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →